Clinical trial Recruiting at 1 site Interventional Ages 16 and up

Agricultural livelihood support for pregnant women to improve food security and birth outcomes

Official title: A Randomized Controlled Trial of an Agricultural Livelihood Intervention to Improve Maternal and Newborn Health and Nutrition in Kenya: Mama Shamba

Run by University of California, San Francisco · NCT07043647 · Data updated 2026-11-12

This program will test whether giving pregnant women farming supplies, training, and access to model farms can reduce household food insecurity and improve birth and infant health for women with and without HIV.

More Pregnancy trials

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment410 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (Nairobi)
StatusRecruiting
StartedSeptember 5, 2025
Main results expectedFebruary 19, 2029
Study endsFebruary 19, 2029
Registry record updatedDecember 12, 2025
Trial IDNCT07043647 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women aged 16 or older at 9–20 weeks' gestation with moderate-to-severe household food insecurity or MUAC <23 cm, who have access to land and permanent surface water and some farming experience.

Probably not a fit

People without access to land or permanent water, those with advanced HIV disease (an exclusion), women beyond the 9–20 week enrollment window, or those planning to relocate within 18 months are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will enroll 410 pregnant women between 9 and 20 weeks' gestation, roughly half of whom are expected to be living with HIV. Participants will be randomly assigned to receive an agricultural livelihood intervention immediately or to receive it after study completion (delayed entry). The intervention includes provision of locally acceptable farming supplies, training, and use of model farms, with implementation support during the perinatal period. Outcomes include household food security, maternal nutrition and health, birth outcomes, and infant growth and development, with follow-up through 12 months postpartum.

Why it matters

Potential benefit: If successful, the intervention could increase household food security and maternal nutrition, leading to fewer adverse birth outcomes and better infant growth.

How similar studies have gone: Some agricultural livelihood programs have improved household food security and income in similar settings, but interventions started during pregnancy are largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant and 9-20 weeks gestation confirmed by ultrasound
* singleton pregnancy
* Age ≥16 years
* moderate-severe household food insecurity or malnutrition (mid-upper arm circumference (MUAC) \<23 cm)
* Access to land and permanent surface water
* self-reported experience with farming

Exclusion Criteria:

* Advanced HIV disease
* Unable to provide written informed consent (use of an impartial witness is satisfactory if illiterate)
* Plans to relocate outside the study area within 18 months

Where it's running

  • Kenya Medical Research Institute
    Nairobi, Kenya
    Recruiting

Study contacts

  • Principal investigator: Craig R Cohen, MD MPH — University of California, San Francisco
  • Study coordinator: Rachel L Burger, MHS
  • Email: rachel.burger@ucsf.edu
  • Phone: 4155352651

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.